Milestone Pharmaceuticals MIST 深 滬
已收盤 08-07 16:00:00 美东时间
1.22
+0.040
+3.39%
華盛通- 最 高1.22
- 今 開1.18
- 成交量 99.01万股
- 最 低 1.16
- 昨 收 1.18
- 總市值 15.19万
- 52周最高 3.06
- 市盈率 靜 --
- 換手率 0.80%
- 52周最低 1.00
- 委 比 2.40%
- 總股本 0.00亿
- 歷史最高 27.95
- 量 比 1.10
- 振 幅 5.08%
- 歷史最低 0.6254
- 每 手 1
- 風險率 0.38%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) will report second-quarter 2026 financial results and provide a business update on Wednesday, August 12, before the market open. A conference call and webcast for investors will follow at 8:30am ET. Registration and dial-in details are available on the company's website. A replay of the webcast will be accessible post-event. Milestone is a biopharmaceutical company focused on innovative cardiovascular...
08-04 20:01
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Milestone Pharmaceuticals Inc. granted 288,000 stock options to six new employees under its 2021 Inducement Plan, with a grant date of July 1, 2026, and an exercise price of $1.32 per share. The options vest over four years, with 25% vesting after the first year and the remainder vesting in 36 monthly installments. The awards are subject to continuous service and comply with Nasdaq Listing Rule 5635(c)(4). Milestone is a biopharmaceutical company...
07-03 01:30
美股大行评级 | 阿里、京东、英伟达、思科等获多家大行上调目标价；Doximity、Dynatrace、Enovix、Wix.com等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Autolus Therapeutics"买入"评级，目标价从9美元升至10美元；Maxim Group：维持Rezolute"买入"评级，目标价从4美元升至10美元
05-15 10:49
Milestone outlines ~2-year Phase III AFib-RVR timeline as CARDAMYST launch reaches ~600 prescriptions
Earnings Call Insights: Milestone Pharmaceuticals (MIST) Q1 2026 Management View “This is an exciting day as it represents our first analyst call reporting on our first ever quarter or, more accuratel...
05-14 01:21
Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported first-quarter earnings on Wednesday before the market opened.
05-13 22:04
Milestone Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript
Milestone Pharmaceuticals (NASDAQ:MIST) held its first-quarter earnings confere...
05-13 21:40
Milestone Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS results.
Milestone Pharmaceuticals shares are trading lower after the company reported w...
05-13 21:26
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
